Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Watson's mexiletine approved

March 6, 1997

Dual NEP/ECE inhibitor for heart failure

March 6, 1997

Potential agent for hypertension and CHF from Roche Bioscience

March 6, 1997

Zeneca presents potent and selective ETA receptor antagonist

March 6, 1997

Senju prepares beta-blocker

March 6, 1997

Lp-PLA2 inhibitors disclosed by SKB

March 5, 1997

ET antagonists from Warner-Lambert

March 5, 1997

Antiarrhythmic agents reported by National Science Council

March 4, 1997

Preliminary phase II data on Xoma's Neuprex in trauma

March 3, 1997

FDA advisory panel approves carvedilol

March 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...